Park Ha Biological Techno... (PHH)
Park Ha Biological Technology Co. Ltd. Statistics
Share Statistics
Park Ha Biological Technology Co. Ltd. has 26.37M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 26.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is -, so null% of the outstanding shares have been sold short.
| Short Interest | - |
| Short % of Shares Out | null% |
| Short % of Float | null% |
| Short Ratio (days to cover) | null |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Park Ha Biological Technology Co. Ltd.'s PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Park Ha Biological Technology Co. Ltd..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.87 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.05 |
| Total Debt / Capitalization | 4.46 |
| Cash Flow / Debt | 13.66 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.32% and return on capital (ROIC) is 30.37%.
| Return on Equity (ROE) | 0.32% |
| Return on Assets (ROA) | 0.16% |
| Return on Capital (ROIC) | 30.37% |
| Revenue Per Employee | $140,108.88 |
| Profits Per Employee | $28,150.65 |
| Employee Count | 17 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.73 |
Taxes
| Income Tax | 314.86K |
| Effective Tax Rate | 0.4 |
Stock Price Statistics
The stock price has increased by 4.73% in the last 52 weeks. The beta is -0.02, so Park Ha Biological Technology Co. Ltd.'s price volatility has been lower than the market average.
| Beta | -0.02 |
| 52-Week Price Change | 4.73% |
| 50-Day Moving Average | 6.85 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 63.37 |
| Average Volume (20 Days) | 193.3K |
Income Statement
In the last 12 months, Park Ha Biological Technology Co. Ltd. had revenue of 2.38M and earned 478.56K in profits. Earnings per share was 0.02.
| Revenue | 2.38M |
| Gross Profit | 2.19M |
| Operating Income | 793.71K |
| Net Income | 478.56K |
| EBITDA | 816.4K |
| EBIT | 793.71K |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 547.5K in cash and 70.32K in debt, giving a net cash position of 477.18K.
| Cash & Cash Equivalents | 547.5K |
| Total Debt | 70.32K |
| Net Cash | 477.18K |
| Retained Earnings | 271.79K |
| Total Assets | 3.08M |
| Working Capital | 1.32M |
Cash Flow
In the last 12 months, operating cash flow was 960.47K and capital expenditures -85.57K, giving a free cash flow of 874.9K.
| Operating Cash Flow | 960.47K |
| Capital Expenditures | -85.57K |
| Free Cash Flow | 874.9K |
| FCF Per Share | 0.03 |
Margins
Gross margin is 91.8%, with operating and profit margins of 33.32% and 20.09%.
| Gross Margin | 91.8% |
| Operating Margin | 33.32% |
| Pretax Margin | 33.31% |
| Profit Margin | 20.09% |
| EBITDA Margin | 34.28% |
| EBIT Margin | 33.32% |
| FCF Margin | 36.73% |
Dividends & Yields
PHH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0.17% |
| FCF Yield | 0.29% |
Analyst Forecast
Currently there are no analyst rating for PHH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 5.87 |
| Piotroski F-Score | 5 |